Is Africa ready to manufacture its own vaccines?

18 October 2021 | Story Staff writer.

On the 26th October 2021, the University of Cape Town (UCT) will host “Vaccines in Africa from Africa”, a live event that will take a deep-dive look at the continent’s capacity for developing and manufacturing vaccines.

Dr Patrick Soon-Shiong, Executive Chairman: ImmunityBio, will present the keynote address at the UCT “Vaccines in Africa from Africa” virtual event. Shiong is a South African-born philan-thropist who has devoted his career to understanding the fundamental biology driving life-threatening diseases and translating these insights into medical innovations with global impact.
Dr Patrick Soon-Shiong, Executive Chairman: ImmunityBio, will present the keynote address at the UCT “Vaccines in Africa from Africa” virtual event. Shiong is a South African-born philan-thropist who has devoted his career to understanding the fundamental biology driving life-threatening diseases and translating these insights into medical innovations with global impact. Photo Supplied.

Gathering industry experts, scientists and business leaders, including keynote speaker, Dr Patrick Soon-Shiong, philanthropist and Executive Chairman of ImmunityBio, the university hopes to highlight the critical need for a vaccine pipeline in Africa, and assess the challenges and opportunities that face such a step.

Among the speakers are:

  • Professor Ed Rybicki, Director: UCT Biopharming Research Unit (BRU)
  • Dr Thanos Kotsiopoulos, UCT Centre for Bioprocess Engineering (CeBER)
  • Professor Tom Scriba, Laboratory Director: South African Tuberculosis Vaccine Initiative (SATVI)
  • Professor Ntobeko Ntusi, Head: UCT Department of Medicine
  • Professor Mary-Ann Davies, Director: UCT Centre for Infectious Disease Epidemiology and Research (CIDER)
  • Prof Rudzani Muloiwa, Head: UCT Department of Paediatrics and Child Health

A panel discussion, chaired by UCT’s Vice Chancellor, Professor Mamokgethi Phakeng, will feature Dr Morena Makhoana, Chief Executive Officer of the BioVac Institute, UCT’s Professor Anna-Lise Williamson, South African Research Chair in Vaccinology Research, Petro Terblanche, Managing Director of Afrigen Biologics and Vaccines, and Emeritus Professor Greg Hussey, Director of Vaccines for Africa (VACFA).

For more information about the event, visit https://bit.ly/3p27Ufn

To register attendance at the event, visit http://www.uct.ac.za/main/webinar/vaccines-in-africa

 

Creative Commons License This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

Please view the republishing articles page for more information.


Research & innovation




UCT aspires to become a premier academic meeting point between South Africa, the rest of Africa and the world. Taking advantage of expanding global networks and our distinct vantage point in Africa, we are committed , through innovative research and scholarship, to grapple with the key issues of our natural and social worlds. We are committed both to protecting and encouraging 'curiosity-driven research' and research that has a real impact on our communities and environment.



 

 




 
TOP